Top Medical News
Neoadjuvant Treatment Crosses Cost-Effective Threshold Vs Upfront Surgery in Pancreatic Cancer
January 27th 2023
Neoadjuvant chemoradiation followed by pancreaticoduodenectomy resulted in 0.14 more quality-of-life years than upfront surgery followed by adjuvant chemotherapy in patients with resectable pancreatic cancer.
Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer
January 27th 2023
Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Auricular Acupuncture Offers Complimentary Approach to Manage Cancer Pain
January 27th 2023
Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, provides a case-based perspective on the benefit of auricular acupuncture as a tool for managing cancer pain.
Greatest Unmet Needs for Patients with Endometrial Cancer
January 27th 2023
The panel shares the most critical unmet needs for patients with endometrial cancer.
Adjuvant Pembrolizumab Gets FDA Approval in NSCLC
January 26th 2023
Pembrolizumab has been approved by the FDA as an adjuvant treatment for patients with stage IB, II, or IIIA following resection and platinum-based chemotherapy.